Loading

Please wait...

Utibron neohaler

Generic Name: glycopyrrolate and indacaterol (inhalation) (GLYE koe PIR oh late and IN da KA ter ol)
Brand Names: Utibron Neohaler
Utibron Neohaler contains a combination of glycopyrrolate and indacaterol. Glycopyrrolate is an anticholinergic. Indacaterol is a bronchodilator. These medications help relax muscles in the airways to improve breathing. Utibron is used to prevent airflow obstruction or bronchospasm in people with COPD.
  • Prescription Settings

Prices and coupons of Utibron neohaler

Current Location: 20149 (Ashburn)
Change Location?

Enter your zip code


Please wait while the prices are loaded...

Don’t see your pharmacy listed? Most pharmacies accept our discounts, so have your pharmacist enter this coupon to see if you will save money:

Drug Information:
Utibron inhalation powder contains a combination of glycopyrrolate and indacaterol. Glycopyrrolate is an anticholinergic. Indacaterol is a bronchodilator. These medications work by relaxing muscles in the airways to improve breathing. Utibron Neohaler is used long term to prevent airflow obstruction or bronchospasm in people with COPD (chronic obstructive pulmonary disease). Utibron Neohaler is not for use in treating asthma. Indacaterol may increase the risk of death in people with asthma, but the risk in people with COPD is not known. Talk with your doctor about your individual risk. Learn more

Utibron neohaler Side Effects

Utibron Neohaler Side Effects

Note: This document contains side effect information about glycopyrrolate / indacaterol. Some of the dosage forms listed on this page may not apply to the brand name Utibron Neohaler.

For the Consumer

Applies to glycopyrrolate/indacaterol: inhalation capsule

Warning

Inhalation route (Capsule)

Indacaterol and glycopyrrolate oral inhalation powder is not indicated for the treatment of asthma. Long-acting beta(2)-adrenergic agonists (LABAs), such as indacaterol, increase the risk of asthma-related death.

Along with its needed effects, glycopyrrolate / indacaterol may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking glycopyrrolate / indacaterol:

Less common

  • Blurred vision
  • dizziness
  • headache
  • nervousness
  • pounding in the ears
  • slow or fast heartbeat

Incidence not known

  • Abdominal or stomach pain
  • blindness
  • convulsions
  • decrease in the frequency of urination
  • decrease in urine volume
  • decreased vision
  • difficulty in passing urine (dribbling)
  • dry mouth
  • eye pain
  • fainting
  • flushed, dry skin
  • fruit-like breath odor
  • hives or welts, itching, or skin rash
  • increased hunger
  • increased thirst
  • increased urination
  • large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs
  • loss of appetite
  • mood changes
  • muscle pain or cramps
  • nausea or vomiting
  • nosebleeds
  • numbness or tingling in the hands, feet, or lips
  • painful urination
  • redness of the skin
  • sweating
  • tearing
  • troubled breathing
  • unexplained weight loss
  • unusual tiredness or weakness
  • vision problems

Some side effects of glycopyrrolate / indacaterol may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common

  • Fever
  • back pain
  • muscle aches
  • sore throat
  • stuffy or runny nose

For Healthcare Professionals

Applies to glycopyrrolate / indacaterol: inhalation capsule

General

The most common adverse reaction was nasopharyngitis and hypertension. Cough was also common, but usually of mild intensity.

Respiratory

Very common (10% or more): Upper and lower respiratory tract infection

Common (1% to 10%): Nasopharyngitis (4.1%), oropharyngeal pain (1.6%), pneumonia, rhinitis, sinusitis, cough, throat irritation

Uncommon (0.1% to 1%): Paradoxical bronchospasm, epistaxis

Very rare (less than 0.01%): Chest pain

Gastrointestinal

Common (1% to 10%): Diarrhea, gastroesophageal reflux disease, dyspepsia, dental caries, gastroenteritis

Uncommon (0.1% to 1%): Dry mouth

Metabolic

Common (1% to 10%): Hyperglycemia

Uncommon (0.1% to 1%): Diabetes mellitus

Musculoskeletal

Common (1% to 10%): Back pain, musculoskeletal pain

Uncommon (0.1% to 1%): Muscle spasm, myalgia, pain in extremity

Nervous system

Common (1% to 10%): Dizziness, headache

Uncommon (0.1% to 1%): Paraesthesia

Other

Common (1% to 10%): Pyrexia

Uncommon (0.1% to 1%): Fatigue, peripheral edema

Cardiovascular

Uncommon (0.1% to 1%): Hypertension (2%), ischemic heart disease, atrial fibrillation, tachycardia, palpitations

Very rare (less than 0.01%): Atrial fibrillation, palpitations, tachycardia

Dermatologic

Uncommon (0.1% to 1%): Angioedema, rash, pruritus

Genitourinary

Uncommon (0.1% to 1%): Bladder obstruction, urinary retention

Ocular

Uncommon (0.1% to 1%): Glaucoma

Psychiatric

Uncommon (0.1% to 1%): Insomnia

Editorial References and Review

Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.

Source: Drugs.com Utibron Neohaler